BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3705086)

  • 1. Effects of methylmercury on hypnotic action of hexobarbital, liver hydroxylase and cytochrome P-450 in mice.
    Su MQ; Okita GT
    Toxicology; 1986 Jun; 39(3):233-45. PubMed ID: 3705086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the effects of methylmercury on ethylmorphine N-demethylase and aniline hydroxylase activities and on the conversion of cytochrome P-450 to cytochrome P-420.
    Alvares AP; Cohn J; Kappas A
    Drug Metab Dispos; 1974; 2(3):259-66. PubMed ID: 4153087
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of hepatic drug-metabolizing enzymes by arachidonic acid.
    Pessayre D; Mazel P; Descatoire V; Rogier E; Feldmann G; Benhamou JP
    Xenobiotica; 1979 May; 9(5):301-10. PubMed ID: 115160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of manganese on the hepatic microsomal mixed function oxidase enzyme system in the rat.
    Deimling MJ; Schnell RC
    Fundam Appl Toxicol; 1984 Dec; 4(6):1009-18. PubMed ID: 6519370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of manganese on hepatic drug metabolism in male and female rats.
    Schnell RC; Deimling MJ
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):307-15. PubMed ID: 6709965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of H2-receptor antagonists on cytochrome P450 in male ICR mice.
    Kim DH; Kim EJ; Han SS; Roh JK; Jeong TC; Park JH
    Hum Exp Toxicol; 1995 Aug; 14(8):623-9. PubMed ID: 7576828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hexachlorophene, tribromsalan, trichlorcarban and cloflucarban on hexobarbital sleeping time and hepatic drug-metabolizing enzyme activity in vitro in the rat.
    Condie LW; Buhler DR
    Biochem Pharmacol; 1979; 28(3):375-80. PubMed ID: 426854
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of Oren-gedoku-to on changes in hexobarbital-induced sleeping time in chlorpromazine-treated mice].
    Sasaki K; Yoshizaki F; Nagasue M; Ando T
    Yakugaku Zasshi; 1994 Jun; 114(6):431-4. PubMed ID: 8051630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potentiation of barbiturate-induced narcosis by procarbazine.
    Lee IP; Lucier GW
    J Pharmacol Exp Ther; 1976 Mar; 196(3):586-93. PubMed ID: 1263114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heredity of hexobarbital sleeping time and efficiency of drug metabolism in Wistar and Sprague-Dawley rats.
    Gut I; Becker BA
    Arch Toxicol; 1975 Sep; 34(1):61-70. PubMed ID: 1242637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat.
    Cherala G; Shapiro BH; D'mello AP
    Drug Metab Dispos; 2007 Jul; 35(7):1057-63. PubMed ID: 17392395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol.
    Borys HK; Ingall GB; Karler R
    Br J Pharmacol; 1979 Sep; 67(1):93-101. PubMed ID: 497524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of furazolidone on duration of righting reflex loss induced with hexobarbital and zoxazolamine in the rat.
    Sasaki N
    J Vet Med Sci; 1994 Aug; 56(4):667-70. PubMed ID: 7999888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of lithium and disulfiram in hexobarbital hypnosis: possible role of the 5-HT system.
    Minegishi A; Fukumori R; Satoh T; Kitagawa H; Yanaura S
    J Pharmacol Exp Ther; 1981 Aug; 218(2):481-7. PubMed ID: 6166742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian rhythm in hexobarbital sleep time: a dose-response evaluation in the mouse.
    Holcslaw TL
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):49-60. PubMed ID: 725321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1,1,1-trichloroethane administered by different routes and in different solvents on barbiturate hypnosis and metabolism in mice.
    Shan HC; Lal H
    J Toxicol Environ Health; 1976 May; 1(5):807-16. PubMed ID: 1271486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of urea on hexobarbital and antipyrine disposition in rats.
    Valentovic M; Bachmann K
    Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian rhythms in drug action and drug metabolism in the mouse.
    Holcslaw TL; Miya TS; Bousquet WS
    J Pharmacol Exp Ther; 1975 Nov; 195(2):320-32. PubMed ID: 1185601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of caffeine on barbiturate sleeping time and brain level.
    Aeschbacher HU; Atkinson J; Domahidy B
    J Pharmacol Exp Ther; 1975 Mar; 192(3):635-41. PubMed ID: 1120961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of hexobarbital in primary cultures of rat hepatocytes maintains cytochrome P-450 levels and drug metabolizing enzyme activities.
    Kim HM; Ha JR; Park SK; Yang KH
    Drug Chem Toxicol; 1988; 11(1):29-41. PubMed ID: 3259924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.